A simple and precise reversed-phase high-performance liquid chromatography method was developed and validated for the determination of 1-fluoronaphthalene and its process-related impurities, 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene. 1-Fluoronaphthalene is the key starting material for the synthesis of duloxetine hydrochloride active pharmaceutical ingredient and is therefore a potential impurity of the API. The determination of the impurity profile is critical for the safety assessment of a substance and manufacturing process thereof. In duloxetine hydrochloride active pharmaceutical ingredient, only 1-fluoronaphthalene is detected and neither of its related impurities of 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene. Chromatography was carried out on a Symmetry C18 (250 3 4.6 mm, 5 mm) column, using mobile phase A-a mixture of 0.01 M KH 2 PO 4 buffer (pH 2.5 + + + + + 0.1):methanol:acetonitrile in the ratio of 35:52:13 v/v/v and mobile phase B-a mixture of methanol:acetonitrile in the ratio of 80:20 v/v at a flow rate of 1.0 mL/min. The analytes were monitored using photo diode array detector at 230 nm. The proposed method is found to be having linearity in the concentration of 0.075 -5.000 mg/mL, 0.150 -5.000 mg/mL, 0.3125-5.000 mg/mL and 0.3125-5.000 mg/mL for 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene, respectively, with correlation coefficients of 0.9998, 0.9998, 0.9997 and 0.9997, respectively. The proposed method was validated as per the International Conference on Harmonization guidelines. The mean recoveries for all the studied impurities are in the range of 90-110%. Due to its specificity, high precision and accuracy, the developed method can be used for the determination of 1-fluoronaphthalene, key starting material for the synthesis of duloxetine hydrochloride API.
Introduction
Duloxetine hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) and it has been approved by the US Food and Drug Administration for the treatment of major depressive disorder and for the diabetic peripheral neuropathic pain. Its chemical designation is (þ)-(S)-N-methylg-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride (1-6; http://wiki.medpedia.com/Clinical: Cymbalta_(Duloxetine_ hydrochloride)). The determination of a drug substance impurity profile, including potential degradation products and processrelated impurities, is critical for the safety assessment of API and manufacturing process thereof. According to the guidelines issued by the International Conference on Harmonization (ICH) and European Pharmacopeia it is mandatory to identify and characterize the impurities in a pharmaceutical product if present above the accepted limits of 0.1%. A literature survey revealed few methods based on reversed-phase high-performance liquid chromatography (RP-HPLC) for the determination of duloxetine hydrochloride API and its key intermediate impurities namely (S)-N, N-dimethyl-3-hydroxy-(2-thienyl)-propanamine (DHTP), 1-naphthol (NPH), phenolic impurity (PHL) duloxetine succinamide (DSM), 2-acetyl thiophene (AT) and N, N-dimethyl-3-keto-(2-thienyl-propanamine) (DKTP) (7) (8) (9) . 1-Fluoronaphthalene is the key starting material in the synthetic route of duloxetine hydrochloride followed by Pharmathen. A reproducible stability-indicating RP-HPLC method was developed and validated as per ICH guidelines, for the quantitative determination of 1-fluoronaphthalene in the presence of its four process-related impurities: 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene (10-13) (Figure 1 ). Based on the in process analysis performed in the laboratory in the final product of duloxetine HCl, only 1-fluoronaphthalene was found to be present in ,0.1%.
Experimental

Reagents
The HPLC-grade acetonitrile, methanol and analytical grade triethylamine, ortho-phosphoric acid and KH 2 PO 4 were purchased from Merck (Germany). Water was prepared by using Millipore Milli-Q water purification system. 1-Fluoronaphthalene and duloxetine hydrochloride were provided by Pharmathen, 1-aminonaphthalene was purchased from Fluka (1360195, purity 99.7%), 2-fluoronaphthalene from Supelco (LB61093, purity 99.9%), naphthalene form Acros Organics (A0285904, purity 99.0%) and 1-nitronaphthalene form Aldrich (103594, purity 99.9%).
Instrumentation
Liquid chromatography was carried out on a Shimadzu HPLC with photodiode array detector. The chromatographic column used was Symmetry C18 (250 Â 4.6 mm i.d., Waters) with 5 mm particles. The separation was achieved on a gradient method. Mobile phase A contained a mixture of 0.01 M KH 2 PO 4 buffer ( pH 2.5 + 0. Preparation of stock solutions and standard solution Twenty-five milligrams accurately weighed of 1-aminonaphth alene, 1-nitronaphthalene, naphthalene, 2-fluoronaphthalene and 1-fluoronaphthalene were diluted separately with 50 mL acetonitrile:water 60:40 v/v to give five solutions containing 500 mg/mL of 1-fluoronaphthalene and each process impurity. Further, 1.0 mL of the stock solutions of 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene was diluted to 10 mL with acetonitrile:water 60:40 v/v to give a solution containing 50 mg/mL of 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene (Solution B).
Fifty milligrams accurately weighed of 1-fluoronaphthalene were diluted with acetonitrile:water 60:40 v/v in 100 mL (solution A) and 5 mL of the solution B were pipetted in the same 100 mL volumetric flask to give a solution containing 500 mg/mL of 1-fluoronaphthalene and 2.5 mg/mL of 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene (standard solution).
Preparation of system suitability solution Two milliliters of 1-fluoronaphthalene stock solution are diluted into 2 mL. System suitability solution concentration 50 mg/mL of 2-fluoronaphthalene and 50 mg/mL of 1-fluoronaphthalene.
Preparation of sample solutions
Twenty-five milligrams of 1-fluoronaphthalene were accurately weighed and dissolved into a 50 mL of acetonitrile/water 60:40 v/v to give a solution containing 500 mg/mL of 1-fluoro naphthalene.
Preparation of spiked sample solutions Fifty milligrams of accurately weighed of 1-fluoronaphthalene was diluted with acetonitrile:water 60:40 v/v in 100 mL, and 5 mL of the solution B were pipetted in the same 100 mL volumetric flask to give a solution containing 500 mg/mL of 1-fluoronaphthalene and 2.5 mg/mL of each impurity.
Method validation
Instrument and method precision
The repeatability of the related substances method was checked by 6-fold analysis of standard solution and 6-fold analysis of test spiked solutions (500 mg/mL of 1-fluoronaphthalene spiked with 2.5 mg/mL of each of 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene). The same protocol was followed for a different analysis date, by a different analyst, with a different column and in a different instrument to check intermediate precision. Different analysts prepared different solutions on a different date. The relative standard deviation (RSD) (%) of peak area and w/w (%) for each impurity were calculated.
Limit of detection and quantification
By injecting a series of solutions of known concentrations limit of detection (LOD) and limit of quantification (LOQ) for 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene were estimated at the amounts for which the signal to noise was 3:1 and 10:1, respectively. 
Accuracy
The accuracy of an analytical procedure expresses the closeness of agreement between the true value and the value found. The accuracy for 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene was evaluated in triplicate at four spiked concentrations at LOQ, 50, 100, 150% level of the analyte concentration (500 mg/mL) and recovery of the impurities was calculated for each added concentration.
Robustness
The robustness of an analytical procedure is a measure of its capacity to remain unaffected by small, but deliberate variations in method parameters. It provides an indication of its reliability during normal usage. To determine the robustness of a method, the experimental conditions were deliberately changed. The effect of column temperature was studied at 25 and 158C (instead of 208C). The mobile phase flow rate was 1.0 mL/min and in order to study the effect of flow rate on resolution it was changed to 0.8 and 1.2 mL/min. The effect of pH was studied at 2.3 and 2.7 (instead of pH 2.5) and the proportion of the organic content in the mobile phase A was studied at 30 and 40% instead of 35%.
Stress studies
Forced degradation of 1-fluoronaphthalene was performed to provide an indication of the stability-indicating properties and specificity of the method. The stress conditions used for the degradation study included UV-light, day light, acid degradation (4.0 M HCl), alkali degradation (4.0 M NaOH), oxidation (3%w/v H 2 O 2 ) and aqueous degradation. The sample preparation for stressed conditions is presented in Table I . The purity of peaks obtained from stressed samples was checked by the use of the photo diode array detector. 
Solution stability
The stability of 1-fluoronaphthalene and its impurities was determined in the test sample, test spiked solutions and standard solutions for 36 h at 208C. The RSD (%) of the peak areas and w/w (%) were calculated for 1-fluoronaphthalene and its four process-related impurities.
Results
The system suitability parameters and acceptance criteria are presented in Table II . A representative chromatogram of 1-fluoronaphthalene in mixture with 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene is illustrated in Figure 2 .
Retention times, relative retention times and resolution between 1-fluoronaphthalene and its impurities are presented in Table III .
Discussion
Precision
The RSD (%) of the peak area for the four impurities namely 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene and 1-fluoronaphthalene in the study of repeatability from the spiked sample solutions was 1.50, 1.59, 2.53, 1.11 and 1.60%, respectively. The RSD (%) of %w/w content for the four impurities was 2.99, 1.75, 1.82 and 2.22%, respectively.
The RSD (%) for the intermediate precision test (different analysts, different dates, different columns and different instruments) for the four impurities namely 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene, and 1-fluoronaphthalene in the six different sample spiked solutions was found to be 0.68, 0.35, 0.64, 0.71 and 2.08%, respectively. The RSD (%) of %w/w content for the four impurities was found to be 1.87, 1.94, 1.73, and 2.00%, respectively. The cumulative %w/w content of all four impurities from the method and intermediate precision test is illustrated in Table IV and the RSD (%) is ,5.0%.
LOD and LOQ
The LOD for 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene was 0.025, 0.025, 0.076 and 0.076 mg/mL, respectively. The LOQ for 1-aminonaphthalene, 1-nitronaphthalene, naphthalene and 2-fluoronaphthalene was 0.076, 0.150L, 0.3125 and 0.3125 mg/mL, respectively ( Table V) .
The correlation coefficient was found to be 0.9998 for 1-aminonaphthalene, 0.9998 for 1-nitronaphthalene, 0.9997 for naphthalene and 0.9997 for 2-fluoronaphthalene.
Accuracy
The accuracy of the method was demonstrated at four different concentration levels in triplicate. The average recovery of 1-aminonaphthalene impurity was found to be 102.22, 100.40, 100.89 and 101.09% at LOQ, 50, 100 and 150% level, respectively. The average recovery of 1-nitronaphthalene was found to be 92.25, 98.14, 99.12 and 98.97% at LOQ, 50, 100 and 150% level, respectively. The average recovery of naphthalene was found to be 102.82, 101.39, 95.30 and 92.75% at LOQ, 50, 100 and 150% level, respectively, and for 2-fluoronaphthalene the percentage average recovery was found to be 102.82, 99.32, 98.83 and 98.41% at LOQ, 50, 100 and 150% level, respectively. The RSD (%) of percentage average recovery at each level for all four impurities was ,5%. Typical HPLC chromatograms obtained from 1-fluoronaphthalene spiked samples with all four impurities at the levels of LOQ concentration for each studied impurity, 1.250 mg/mL (50%), 2.500 mg/mL (100%) and 3.750 mg/mL (150%), are shown in Figure 3 .
Robustness
In all the deliberate chromatographic conditions (flow rate, column temperature, pH variation and different proportion of the organic solvent in the mobile phase), all analytes were adequately resolved and elution orders remained unchanged. Resolution between 2-fluoronaphthalene and 1-fluoronaphthalene was .3.5 for all % RSD peak area % RSD %w/w % RSD peak area % RSD %w/w % RSD peak area % RSD %w/w % RSD peak area % RSD %w/w % RSD peak area % RSD %w/w 258C flow rate (1.0, 0.8 and 1.2 mL/min), column temperature (20, 25 and 158C), pH (2.5, 2.3 and 2.7) and organic content composition of the mobile phase (30, 40%) variation conditions. The RSD (%) of the peak area and %w/w content of each impurity from the spiked sample solutions at each variable condition were ,10.0% (Tables VI and VII ; Supplementary Material, Figure S1 )
Forced degradation studies Degradation was not observed when 1-fluoronaphthalene was subjected to oxidative, light, acidic, basic and aqueous degradation ( Figure 4 ).
Solution stability
The RSD (%) of peak area and %w/w content of 1-fluoro naphthalene during solution stability experiment from standard and sample spiked solution were ,1.0%. The RSD (%) of peak area and %w/w content of 1-aminonaphthalene, 1-nitronaph thalene, naphthalene and 2-fluoronaphthalene standard and spiked sample solutions were ,2.0%. No significant changes in the amounts of the four impurities were observed during solution stability. The results from solution stability experiment confirmed that standard solutions and sample spiked solutions were stable up to 36 h during determination of related substances. Typical chromatograms of standard and spiked sample solution at zero time and after 36 h are presented in Supplementary Material, Figure S2 .
